Results 101 to 110 of about 4,766 (189)

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025. [PDF]

Euro Surveill
van Kampen J, Voermans J, Soochit W, Mesplède T, van de Laar T, van der Reijden W, Burger D, Shalev N, van Sighem A, Bezemer D, Jurriaans S, van der Vaart T, de Jong H, van der Valk M.   +13 more
europepmc   +1 more source

Evolution and forecasting of antiretroviral therapy utilisation in British Columbia: a population-level analysis of provincial drug treatment programme data, 2014-2024. [PDF]

BMJ Open
Lima VD, Mokhtari Jazi A, Montaner JSG.
europepmc   +1 more source

Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study. [PDF]

J Exp Pharmacol
Rao AM, Sm F, Somashekara D, Gayam PKR, Rahangdale RR, Patil SS, Hariharapura RC.   +6 more
europepmc   +1 more source

Alternative Administration of Antiretroviral Therapy in People with HIV Unable to Swallow: A Scoping Review. [PDF]

HIV AIDS (Auckl)
Abdessamad H, Baroody C, Pogorzelski K, Jamaleddine W, Kitonga MS, Omar H, Amankrah SA, Allen-Brown K, Dandachi D.   +8 more
europepmc   +1 more source

Immediate and delayed switches to tenofovir DF-containing, ainuovirine-based antiretroviral regimen: the SPRINT extensional study. [PDF]

BMC Med
Zhang F, Cai W, Wu H, Ma P, Zhao Q, Wei H, Lu H, Wang H, He S, Chen Z, Chen Y, Wang M, Yun X, Zhou Z, Fu H, Qin H.   +15 more
europepmc   +1 more source

Integrase Strand Transfer Inhibitors for Treatment-experienced Young Adults With Perinatal HIV in the US: Immunologic, Virologic, and Anthropometric Outcomes. [PDF]

Clin Infect Dis
Patel K, Jaramillo-Underwood A, Karalius B, Yao TJ, Van Dyke RB, Mirza A, Jao J, Agwu AL, Pediatric HIV/AIDS Cohort Study (PHACS) .   +8 more
europepmc   +1 more source

Confronting Dual Therapeutic Hurdles in Advanced HIV: A Case Report on INSTIs Resistance and Talaromyces marneffei Coinfection. [PDF]

Int Med Case Rep J
Zou L, Diao Y, Huang Z, You C.
europepmc   +1 more source

Contemporary antiretroviral pharmacology in the male genital tract: implications for HIV treatment and prevention. [PDF]

Antimicrob Agents Chemother
Neverette NC, Winfield J, Chaparro-Cáceres N, Ho KS, Dumond JB, Devanathan AS.   +5 more
europepmc   +1 more source

Assessing phenotypic effect of integrase strand-transfer inhibitor (INSTI)-based resistance substitutions associated with failures on cabotegravir. [PDF]

J Antimicrob Chemother
D'Antoni ML, Falkard B, Andreatta K, Cox S, Cohen C, Callebaut C.   +5 more
europepmc   +1 more source

Prevalence of acquired resistance to HIV integrase strand transfer inhibitors (INSTIs) in clinical samples from treatment-experienced patients in Chile, 2012-2023. [PDF]

J Virus Erad
Ferrer P, Ramos V, Durán M, Maureira D, Beltrán C, Afani A.   +5 more
europepmc   +1 more source